CRP/SAA Combo Test Kit

As serological inflammatory marker, C-Reactive Protein (CRP) and Serum Amyloid A (SAA) are used to assist the preliminary diagnosis of the types of bacterial and viral infections.

Features:

Detection range: CRP: 0-200mg/L; SAA: 0-200mg/L

Detection time: 5 min

Specificity: 98%

Sensitivity: 98%

Request Quote

零售价

0.0

元

市场价

0.0

元

浏览量:

1000

产品编号

所属分类

Inflammation

数量

库存:



Details

Photos

Video

Summary
C-reactive protein (CRP) and Serum amyloid A (SAA) are acute phase proteins. Measuring their concentration in serum helps diagnose inflflammation, evaluate its activity, monitor its activity and treatment. Compared with the traditional inflflammatory marker white blood cell, its advantage is that the virus infection also causes its

signifificant increase, it is a sensitive indicator for the diagnosis of virus infection. The combined detection of SAA and CRP can provide strong evidence for the early diagnosis of infectious diseases (such as neonatal sepsis and sepsis).
Intended Use
CRP/SAA Combo Test Kit is used for the in vitro qualitative detection of C-Reactive Protein/Serum Amyloid A (CRP/SAA) content in human whole blood, plasma and serum. This reagent uses colloidal gold double antibody sandwich method to qualitatively detect the concentration of CRP/SAA in human whole blood, plasma, and serum samples. After the diluted sample is dropped into the sample well of the cassette, the serum amyloid A (SAA) in the sample and the colloidal gold-labeled anti-serum amyloid A (SAA) monoclonal antibody I combine to form an immune reaction complex. The complex moves forward along the nitrocellulose membrane, and is captured by the antiserum amyloid A (SAA) monoclonal antibody II in the T2 detection area of the nitrocellulose membrane, forming a detection line; The C-reactive

protein (CRP) in the sample and the colloidal gold-labeled anti-C-reactive protein (CRP) monoclonal antibody I combine to form an immune reaction complex, which moves forward along the nitrocellulose membrane, the anti-C-reactive protein (CRP) monoclonal antibody II in the T1 detection area of the plain membrane is captured

to form a detection line. The more analytes in the sample, the more complexes accumulated on the detection line, and the intensity of the detection line reflflects the content of the analyte captured. The colloidal gold-labeled antibody that is not captured in the detection area moves forward along the nitrocellulose membrane and

combines with the quality control antibody in the quality control area to form a quality control signal.